Titan About
Titan: Titan Pharmaceuticals, Inc. (ASE: TTP) is a biopharmaceutical
company focused on the development and commercialization of novel treatments for
central nervous system disorders, cancer and cardiovascular disease. Titan’s products
in development utilize novel technologies that have the potential to significantly
improve the treatment of these diseases. Titan also establishes partnerships with
government institutions and other leading pharmaceutical development companies.
Titan's product development pipeline includes six products in clinical testing:
More
on Titan:
Key
Statistics for Titan
Phase
II Pivanex Refractory
Chronic Lymphocytic Leukemia Phase
II DITPA Congestive
Heart Failure Phase
I/II Probuphine opiate
addition Phase
II Spheramine Advanced
Parkinson's Phase
III Iloperidone
Schizophrenia
Gallium
Maltolate Bone
Disease
Basic
Chart for Titan